<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>SOLACE2 clinical trial &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/solace2-clinical-trial/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 12 Nov 2025 14:17:54 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>SOLACE2 clinical trial &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>New Blood Test Paves the Way for More Effective Ovarian Cancer Treatments</title>
		<link>https://bioengineer.org/new-blood-test-paves-the-way-for-more-effective-ovarian-cancer-treatments/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 12 Nov 2025 14:17:27 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Ovarian cancer]]></category>
		<category><![CDATA[PARP inhibitors]]></category>
		<category><![CDATA[personalized cancer treatment]]></category>
		<category><![CDATA[SOLACE2 clinical trial]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-blood-test-paves-the-way-for-more-effective-ovarian-cancer-treatments/</guid>

					<description><![CDATA[Every year, more than 300,000 women worldwide receive the devastating diagnosis of ovarian cancer, a disease notorious for its complexity and tendency to present at advanced stages. The fight against ovarian cancer is arduous, often hindered by the challenges of tailoring effective therapies to the unique molecular landscapes of individual tumors. Now, a groundbreaking clinical [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">295401</post-id>	</item>
	</channel>
</rss>
